Sales rise 18.29% to Rs 359.05 crore
Net profit of Caplin Point Laboratories rose 22.26% to Rs 91.67 crore in the quarter ended September 2022 as against Rs 74.98 crore during the previous quarter ended September 2021. Sales rose 18.29% to Rs 359.05 crore in the quarter ended September 2022 as against Rs 303.53 crore during the previous quarter ended September 2021. ParticularsQuarter EndedSep. 2022Sep. 2021% Var.Sales359.05303.53 18 OPM %29.4033.33 -PBDT121.91109.45 11 PBT110.4597.73 13 NP91.6774.98 22Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
